Dear Editor: As my first reaction, I thought; yes, pharmaceutical companies are inventing syndromes. [See “Are Drug Firms Disease-Mongering?” MM June, page 10.] However, after some reflection I believe that they are merely looking at different disease states or conditions that their products may help to alleviate. The real questions are: How important is the condition, disease, or syndrome to the affected individual? Does mass communication; i.e., television and print campaigns,
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments